世界の閉経後骨粗鬆症治療薬市場2016

【英語タイトル】Global Postmenopausal Osteoporosis Drug Market Research Report 2016

QYResearchが出版した調査資料(QYR61224541)・商品コード:QYR61224541
・発行会社(調査会社):QYResearch
・発行日:2016年10月5日
・ページ数:119
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療・製薬
◆販売価格オプション(消費税別)
Single UserUSD2,900 ⇒換算¥327,700見積依頼/購入/質問フォーム
Enterprise(全社内共有可)USD5,800 ⇒換算¥655,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日~2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
※当調査レポートでは、世界の閉経後骨粗鬆症治療薬市場について調査・分析し、市場概観、市場動向、閉経後骨粗鬆症治療薬の世界市場規模、市場予測、地域別市場規模(日本市場、中国市場、米国市場、欧州市場など)、用途別市場分析、製造コスト分析、主要なメーカー分析(企業概要、主な製品概要、生産・販売動向、連絡先など)、種類別価格分析、価格情報、市場環境分析、輸出・輸入データ、市場シェア分析などを含め、以下の構成でお届けいたします。

・閉経後骨粗鬆症治療薬の世界市場:市場概要
・閉経後骨粗鬆症治療薬の世界市場:市場動向
・閉経後骨粗鬆症治療薬の世界市場:市場規模、市場規模予測
・閉経後骨粗鬆症治療薬の地域別市場規模(日本市場、中国市場、アメリカ市場、ヨーロッパ市場など)
・閉経後骨粗鬆症治療薬の世界市場:用途別市場分析
・閉経後骨粗鬆症治療薬の製造コスト分析
・閉経後骨粗鬆症治療薬の企業間競争状況
・閉経後骨粗鬆症治療薬の主要なメーカー分析(企業情報、主な製品概要、生産・販売動向、連絡先など)
・閉経後骨粗鬆症治療薬の種類別価格分析
・閉経後骨粗鬆症治療薬の価格動向
・閉経後骨粗鬆症治療薬の世界市場:市場環境分析
・閉経後骨粗鬆症治療薬の世界市場:輸出・輸入データ
・閉経後骨粗鬆症治療薬の世界市場:市場シェア分析
・閉経後骨粗鬆症治療薬の世界市場:結論
...
【レポートの概要】

Notes:Production, means the output of Postmenopausal Osteoporosis Drug
Revenue, means the sales value of Postmenopausal Osteoporosis Drug

This report studies Postmenopausal Osteoporosis Drug in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering
Eli Lilly
Amgen
Merck
Novartis
Allergan
Amgen Astellas Biopharm
Deltanoid Pharmaceuticals
Noven
Novo Nordisk
Osteologix
Pfizer
PhytoHealth
Radius Health
Tarsa Therapeutics
UCB
Uni-Bio Science Group
Upsher-Smith Laboratories
Watson Pharmaceuticals
Zosano Pharma
Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Postmenopausal Osteoporosis Drug in these regions, from 2011 to 2021 (forecast), like
North America
Europe
China
Japan
Southeast Asia
India
Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Type III
Split by application, this report focuses on consumption, market share and growth rate of Postmenopausal Osteoporosis Drug in each application, can be divided into
Application 1
Application 2
Application 3

【レポートの目次】

Table of Contents

Global Postmenopausal Osteoporosis Drug Market Research Report 2016
1 Postmenopausal Osteoporosis Drug Market Overview
1.1 Product Overview and Scope of Postmenopausal Osteoporosis Drug
1.2 Postmenopausal Osteoporosis Drug Segment by Type
1.2.1 Global Production Market Share of Postmenopausal Osteoporosis Drug by Type in 2015
1.2.2 Type I
1.2.3 Type II
1.2.4 Type III
1.3 Postmenopausal Osteoporosis Drug Segment by Application
1.3.1 Postmenopausal Osteoporosis Drug Consumption Market Share by Application in 2015
1.3.2 Application 1
1.3.3 Application 2
1.3.4 Application 3
1.4 Postmenopausal Osteoporosis Drug Market by Region
1.4.1 North America Status and Prospect (2011-2021)
1.4.2 Europe Status and Prospect (2011-2021)
1.4.3 China Status and Prospect (2011-2021)
1.4.4 Japan Status and Prospect (2011-2021)
1.4.5 Southeast Asia Status and Prospect (2011-2021)
1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of Postmenopausal Osteoporosis Drug (2011-2021)

2 Global Postmenopausal Osteoporosis Drug Market Competition by Manufacturers
2.1 Global Postmenopausal Osteoporosis Drug Production and Share by Manufacturers (2015 and 2016)
2.2 Global Postmenopausal Osteoporosis Drug Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Postmenopausal Osteoporosis Drug Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Postmenopausal Osteoporosis Drug Manufacturing Base Distribution, Sales Area and Product Type
2.5 Postmenopausal Osteoporosis Drug Market Competitive Situation and Trends
2.5.1 Postmenopausal Osteoporosis Drug Market Concentration Rate
2.5.2 Postmenopausal Osteoporosis Drug Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Postmenopausal Osteoporosis Drug Production, Revenue (Value) by Region (2011-2016)
3.1 Global Postmenopausal Osteoporosis Drug Production and Market Share by Region (2011-2016)
3.2 Global Postmenopausal Osteoporosis Drug Revenue (Value) and Market Share by Region (2011-2016)
3.3 Global Postmenopausal Osteoporosis Drug Production, Revenue, Price and Gross Margin (2011-2016)
3.4 North America Postmenopausal Osteoporosis Drug Production, Revenue, Price and Gross Margin (2011-2016)
3.5 Europe Postmenopausal Osteoporosis Drug Production, Revenue, Price and Gross Margin (2011-2016)
3.6 China Postmenopausal Osteoporosis Drug Production, Revenue, Price and Gross Margin (2011-2016)
3.7 Japan Postmenopausal Osteoporosis Drug Production, Revenue, Price and Gross Margin (2011-2016)
3.8 Southeast Asia Postmenopausal Osteoporosis Drug Production, Revenue, Price and Gross Margin (2011-2016)
3.9 India Postmenopausal Osteoporosis Drug Production, Revenue, Price and Gross Margin (2011-2016)

4 Global Postmenopausal Osteoporosis Drug Supply (Production), Consumption, Export, Import by Regions (2011-2016)
4.1 Global Postmenopausal Osteoporosis Drug Consumption by Regions (2011-2016)
4.2 North America Postmenopausal Osteoporosis Drug Production, Consumption, Export, Import by Regions (2011-2016)
4.3 Europe Postmenopausal Osteoporosis Drug Production, Consumption, Export, Import by Regions (2011-2016)
4.4 China Postmenopausal Osteoporosis Drug Production, Consumption, Export, Import by Regions (2011-2016)
4.5 Japan Postmenopausal Osteoporosis Drug Production, Consumption, Export, Import by Regions (2011-2016)
4.6 Southeast Asia Postmenopausal Osteoporosis Drug Production, Consumption, Export, Import by Regions (2011-2016)
4.7 India Postmenopausal Osteoporosis Drug Production, Consumption, Export, Import by Regions (2011-2016)

5 Global Postmenopausal Osteoporosis Drug Production, Revenue (Value), Price Trend by Type
5.1 Global Postmenopausal Osteoporosis Drug Production and Market Share by Type (2011-2016)
5.2 Global Postmenopausal Osteoporosis Drug Revenue and Market Share by Type (2011-2016)
5.3 Global Postmenopausal Osteoporosis Drug Price by Type (2011-2016)
5.4 Global Postmenopausal Osteoporosis Drug Production Growth by Type (2011-2016)

6 Global Postmenopausal Osteoporosis Drug Market Analysis by Application
6.1 Global Postmenopausal Osteoporosis Drug Consumption and Market Share by Application (2011-2016)
6.2 Global Postmenopausal Osteoporosis Drug Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries

7 Global Postmenopausal Osteoporosis Drug Manufacturers Profiles/Analysis
7.1 Eli Lilly
7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
7.1.2 Postmenopausal Osteoporosis Drug Product Type, Application and Specification
7.1.2.1 Type I
7.1.2.2 Type II
7.1.3 Eli Lilly Postmenopausal Osteoporosis Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
7.1.4 Main Business/Business Overview
7.2 Amgen
7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
7.2.2 Postmenopausal Osteoporosis Drug Product Type, Application and Specification
7.2.2.1 Type I
7.2.2.2 Type II
7.2.3 Amgen Postmenopausal Osteoporosis Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
7.2.4 Main Business/Business Overview
7.3 Merck
7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
7.3.2 Postmenopausal Osteoporosis Drug Product Type, Application and Specification
7.3.2.1 Type I
7.3.2.2 Type II
7.3.3 Merck Postmenopausal Osteoporosis Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
7.3.4 Main Business/Business Overview
7.4 Novartis
7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
7.4.2 Postmenopausal Osteoporosis Drug Product Type, Application and Specification
7.4.2.1 Type I
7.4.2.2 Type II
7.4.3 Novartis Postmenopausal Osteoporosis Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
7.4.4 Main Business/Business Overview
7.5 Allergan
7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
7.5.2 Postmenopausal Osteoporosis Drug Product Type, Application and Specification
7.5.2.1 Type I
7.5.2.2 Type II
7.5.3 Allergan Postmenopausal Osteoporosis Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
7.5.4 Main Business/Business Overview
7.6 Amgen Astellas Biopharm
7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
7.6.2 Postmenopausal Osteoporosis Drug Product Type, Application and Specification
7.6.2.1 Type I
7.6.2.2 Type II
7.6.3 Amgen Astellas Biopharm Postmenopausal Osteoporosis Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
7.6.4 Main Business/Business Overview
7.7 Deltanoid Pharmaceuticals
7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
7.7.2 Postmenopausal Osteoporosis Drug Product Type, Application and Specification
7.7.2.1 Type I
7.7.2.2 Type II
7.7.3 Deltanoid Pharmaceuticals Postmenopausal Osteoporosis Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
7.7.4 Main Business/Business Overview
7.8 Noven
7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
7.8.2 Postmenopausal Osteoporosis Drug Product Type, Application and Specification
7.8.2.1 Type I
7.8.2.2 Type II
7.8.3 Noven Postmenopausal Osteoporosis Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
7.8.4 Main Business/Business Overview
7.9 Novo Nordisk
7.9.1 Company Basic Information, Manufacturing Base and Its Competitors
7.9.2 Postmenopausal Osteoporosis Drug Product Type, Application and Specification
7.9.2.1 Type I
7.9.2.2 Type II
7.9.3 Novo Nordisk Postmenopausal Osteoporosis Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
7.9.4 Main Business/Business Overview
7.10 Osteologix
7.10.1 Company Basic Information, Manufacturing Base and Its Competitors
7.10.2 Postmenopausal Osteoporosis Drug Product Type, Application and Specification
7.10.2.1 Type I
7.10.2.2 Type II
7.10.3 Osteologix Postmenopausal Osteoporosis Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
7.10.4 Main Business/Business Overview
7.11 Pfizer
7.12 PhytoHealth
7.13 Radius Health
7.14 Tarsa Therapeutics
7.15 UCB
7.16 Uni-Bio Science Group
7.17 Upsher-Smith Laboratories
7.18 Watson Pharmaceuticals
7.19 Zosano Pharma

8 Postmenopausal Osteoporosis Drug Manufacturing Cost Analysis
8.1 Postmenopausal Osteoporosis Drug Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Postmenopausal Osteoporosis Drug

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Postmenopausal Osteoporosis Drug Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Postmenopausal Osteoporosis Drug Major Manufacturers in 2015
9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 Global Postmenopausal Osteoporosis Drug Market Forecast (2016-2021)
12.1 Global Postmenopausal Osteoporosis Drug Production, Revenue Forecast (2016-2021)
12.2 Global Postmenopausal Osteoporosis Drug Production, Consumption Forecast by Regions (2016-2021)
12.3 Global Postmenopausal Osteoporosis Drug Production Forecast by Type (2016-2021)
12.4 Global Postmenopausal Osteoporosis Drug Consumption Forecast by Application (2016-2021)
12.5 Postmenopausal Osteoporosis Drug Price Forecast (2016-2021)

13 Research Findings and Conclusion

14 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer

List of Tables and Figures

Figure Picture of Postmenopausal Osteoporosis Drug
Figure Global Production Market Share of Postmenopausal Osteoporosis Drug by Type in 2015
Figure Product Picture of Type I
Table Major Manufacturers of Type I
Figure Product Picture of Type II
Table Major Manufacturers of Type II
Figure Product Picture of Type III
Table Major Manufacturers of Type III
Table Postmenopausal Osteoporosis Drug Consumption Market Share by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Application 3 Examples
Figure North America Postmenopausal Osteoporosis Drug Revenue (Million USD) and Growth Rate (2011-2021)
Figure Europe Postmenopausal Osteoporosis Drug Revenue (Million USD) and Growth Rate (2011-2021)
Figure China Postmenopausal Osteoporosis Drug Revenue (Million USD) and Growth Rate (2011-2021)
Figure Japan Postmenopausal Osteoporosis Drug Revenue (Million USD) and Growth Rate (2011-2021)
Figure Southeast Asia Postmenopausal Osteoporosis Drug Revenue (Million USD) and Growth Rate (2011-2021)
Figure India Postmenopausal Osteoporosis Drug Revenue (Million USD) and Growth Rate (2011-2021)
Figure Global Postmenopausal Osteoporosis Drug Revenue (Million UDS) and Growth Rate (2011-2021)
Table Global Postmenopausal Osteoporosis Drug Production of Key Manufacturers (2015 and 2016)
Table Global Postmenopausal Osteoporosis Drug Production Share by Manufacturers (2015 and 2016)
Figure 2015 Postmenopausal Osteoporosis Drug Production Share by Manufacturers
Figure 2016 Postmenopausal Osteoporosis Drug Production Share by Manufacturers
Table Global Postmenopausal Osteoporosis Drug Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Postmenopausal Osteoporosis Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Postmenopausal Osteoporosis Drug Revenue Share by Manufacturers
Table 2016 Global Postmenopausal Osteoporosis Drug Revenue Share by Manufacturers
Table Global Market Postmenopausal Osteoporosis Drug Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Postmenopausal Osteoporosis Drug Average Price of Key Manufacturers in 2015
Table Manufacturers Postmenopausal Osteoporosis Drug Manufacturing Base Distribution and Sales Area
Table Manufacturers Postmenopausal Osteoporosis Drug Product Type
Figure Postmenopausal Osteoporosis Drug Market Share of Top 3 Manufacturers
Figure Postmenopausal Osteoporosis Drug Market Share of Top 5 Manufacturers
Table Global Postmenopausal Osteoporosis Drug Production by Regions (2011-2016)
Figure Global Postmenopausal Osteoporosis Drug Production and Market Share by Regions (2011-2016)
Figure Global Postmenopausal Osteoporosis Drug Production Market Share by Regions (2011-2016)
Figure 2015 Global Postmenopausal Osteoporosis Drug Production Market Share by Regions
Table Global Postmenopausal Osteoporosis Drug Revenue by Regions (2011-2016)
Table Global Postmenopausal Osteoporosis Drug Revenue Market Share by Regions (2011-2016)
Table 2015 Global Postmenopausal Osteoporosis Drug Revenue Market Share by Regions
Table Global Postmenopausal Osteoporosis Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table North America Postmenopausal Osteoporosis Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table Europe Postmenopausal Osteoporosis Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table China Postmenopausal Osteoporosis Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table Japan Postmenopausal Osteoporosis Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table Southeast Asia Postmenopausal Osteoporosis Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table India Postmenopausal Osteoporosis Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table Global Postmenopausal Osteoporosis Drug Consumption Market by Regions (2011-2016)
Table Global Postmenopausal Osteoporosis Drug Consumption Market Share by Regions (2011-2016)
Figure Global Postmenopausal Osteoporosis Drug Consumption Market Share by Regions (2011-2016)
Figure 2015 Global Postmenopausal Osteoporosis Drug Consumption Market Share by Regions
Table North America Postmenopausal Osteoporosis Drug Production, Consumption, Import & Export (2011-2016)
Table Europe Postmenopausal Osteoporosis Drug Production, Consumption, Import & Export (2011-2016)
Table China Postmenopausal Osteoporosis Drug Production, Consumption, Import & Export (2011-2016)
Table Japan Postmenopausal Osteoporosis Drug Production, Consumption, Import & Export (2011-2016)
Table Southeast Asia Postmenopausal Osteoporosis Drug Production, Consumption, Import & Export (2011-2016)
Table India Postmenopausal Osteoporosis Drug Production, Consumption, Import & Export (2011-2016)
Table Global Postmenopausal Osteoporosis Drug Production by Type (2011-2016)
Table Global Postmenopausal Osteoporosis Drug Production Share by Type (2011-2016)
Figure Production Market Share of Postmenopausal Osteoporosis Drug by Type (2011-2016)
Figure 2015 Production Market Share of Postmenopausal Osteoporosis Drug by Type
Table Global Postmenopausal Osteoporosis Drug Revenue by Type (2011-2016)
Table Global Postmenopausal Osteoporosis Drug Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Postmenopausal Osteoporosis Drug by Type (2011-2016)
Figure 2015 Revenue Market Share of Postmenopausal Osteoporosis Drug by Type
Table Global Postmenopausal Osteoporosis Drug Price by Type (2011-2016)
Figure Global Postmenopausal Osteoporosis Drug Production Growth by Type (2011-2016)
Table Global Postmenopausal Osteoporosis Drug Consumption by Application (2011-2016)
Table Global Postmenopausal Osteoporosis Drug Consumption Market Share by Application (2011-2016)
Figure Global Postmenopausal Osteoporosis Drug Consumption Market Share by Application in 2015
Table Global Postmenopausal Osteoporosis Drug Consumption Growth Rate by Application (2011-2016)
Figure Global Postmenopausal Osteoporosis Drug Consumption Growth Rate by Application (2011-2016)
Table Eli Lilly Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eli Lilly Postmenopausal Osteoporosis Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Eli Lilly Postmenopausal Osteoporosis Drug Market Share (2011-2016)
Table Amgen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Amgen Postmenopausal Osteoporosis Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Amgen Postmenopausal Osteoporosis Drug Market Share (2011-2016)
Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Postmenopausal Osteoporosis Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Merck Postmenopausal Osteoporosis Drug Market Share (2011-2016)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Postmenopausal Osteoporosis Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Novartis Postmenopausal Osteoporosis Drug Market Share (2011-2016)
Table Allergan Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Allergan Postmenopausal Osteoporosis Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Allergan Postmenopausal Osteoporosis Drug Market Share (2011-2016)
Table Amgen Astellas Biopharm Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Amgen Astellas Biopharm Postmenopausal Osteoporosis Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Amgen Astellas Biopharm Postmenopausal Osteoporosis Drug Market Share (2011-2016)
Table Deltanoid Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Deltanoid Pharmaceuticals Postmenopausal Osteoporosis Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Deltanoid Pharmaceuticals Postmenopausal Osteoporosis Drug Market Share (2011-2016)
Table Noven Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Noven Postmenopausal Osteoporosis Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Noven Postmenopausal Osteoporosis Drug Market Share (2011-2016)
Table Novo Nordisk Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novo Nordisk Postmenopausal Osteoporosis Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Novo Nordisk Postmenopausal Osteoporosis Drug Market Share (2011-2016)
Table Osteologix Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Osteologix Postmenopausal Osteoporosis Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Osteologix Postmenopausal Osteoporosis Drug Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Postmenopausal Osteoporosis Drug
Figure Manufacturing Process Analysis of Postmenopausal Osteoporosis Drug
Figure Postmenopausal Osteoporosis Drug Industrial Chain Analysis
Table Raw Materials Sources of Postmenopausal Osteoporosis Drug Major Manufacturers in 2015
Table Major Buyers of Postmenopausal Osteoporosis Drug
Table Distributors/Traders List
Figure Global Postmenopausal Osteoporosis Drug Production and Growth Rate Forecast (2016-2021)
Figure Global Postmenopausal Osteoporosis Drug Revenue and Growth Rate Forecast (2016-2021)
Table Global Postmenopausal Osteoporosis Drug Production Forecast by Regions (2016-2021)
Table Global Postmenopausal Osteoporosis Drug Consumption Forecast by Regions (2016-2021)
Table Global Postmenopausal Osteoporosis Drug Production Forecast by Type (2016-2021)
Table Global Postmenopausal Osteoporosis Drug Consumption Forecast by Application (2016-2021)


★調査レポート[世界の閉経後骨粗鬆症治療薬市場2016] (コード:QYR61224541)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の閉経後骨粗鬆症治療薬市場2016]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆